Drug-makers Amgen and Johnson & Johnson are voluntarily recalling two brands of an injectable anemia medication because of the possibility that vials of it may also contain tiny glass flakes. The drug, Epoetin alfa, is marketed under the brand names Epogen and Procrit. Continue reading Amgen Recalls Anemia Medications Epogen and Procrit Over Glass Fragments Amgen Recalls Anemia Medications Epogen and Procrit Over Glass Fragments originally appeared on DailyFinance on Fri, 24 Sep 2010 11:55:00. Filed Under: Company News , Health Care , Johnson & Johnson , Amgen Permalink | Tweet this! | Comments